Breaking News
Top News
-
Equitable, Corebridge Unveil Transformational All-Stock Merger, Target $500M Synergies by 2028
-
HSBC Thinks Tesla Stock Could Fall 65%. Here’s Why.
-
Why Lenz Therapeutics Stock Plummeted by Almost 20% This Week
-
Best same-day emergency loans for April 2026: Get fast funding after approval
-
LA Mayor: Number One Issue Facing City Is Affordability
-
Man arrested in plot to firebomb Palestinian activist’s home after undercover op
-
Textron Inc. (TXT) Strengthens H‑1 Fleet Through Structural and Power Enhancements
-
Outdoor Holding Company (POWW) Expands GunBroker With AI Innovation
-
What Do Financial Advisors Make for Selling Annuities?
-
Clarus Corporation (CLAR) Navigates Market Headwinds With Cost Discipline
-
What Is an Exchange Fund? Investment Benefits and Risks
-
Sportsman’s Warehouse Holdings (SPWH) Balances Growth With Strategic Streamlining
-
Northrop Grumman (NOC) Advances Autonomous Flight Capabilities With Talon IQ
-
American Outdoor Brands (AOUT) Shows Resilience Amid Mixed Category Trends
-
Sturm, Ruger & Company (RGR) Faces Shareholder Tensions Amid Beretta Dispute
-
US, Israel Hit Nuclear Targets as Iran Vows Retaliation
-
Is Smith & Wesson Brands (SWBI) One of the Best Gun Stocks to Buy in 2026?
-
The Justice Department plans to share sensitive voter data with Homeland Security
-
Is MannKind Corporation (MNKD) One of the Popular Penny Stocks on Robinhood to Buy?
-
CytomX Therapeutics (CTMX) Gains Analyst Confidence on Trial Progress
2026-02-05



































